NCT02242942 · OUTCOME

Overall Survival (OS)

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia · Source last updated 2025-11-06

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Baseline until death, up to approximately 10.75 years

What was measured

OS was defined as the time between the date of randomization and the date of death due to any cause.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

anticipated Posting Date: 2026-08
denom Units Selected: Participants
description: OS was defined as the time between the date of randomization and the date of death due to any cause.
reporting Status: NOT_POSTED
time Frame: Baseline until death, up to approximately 10.75 years
title: Overall Survival (OS)
type: SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice